Tayyab Rehman

Dr. Tayyab Rehman

Medicine, University of Michigan, Ann Arbor, Michigan, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
TRTayyab Rehman
Tayyab Rehman
Changing demographics have made aging and age-related chronic diseases an enormous and growing biomedical and societal challenge. The biological processes of aging may involve a role for the gut microbiota. Aspects of host physiology such as immune homeostasis and energy balance are profoundly influenced by the microbiota. Immune dysregulation characterizes old age and constitutes a major pathomechanism underlying frailty and age-associated chronic diseases. A growing body of literature implicates age-related perturbations in the gut microbial ecology as contributing to a global inflammatory state in the elderly. A better understanding of the nature and determinants of the host-microbe relationship in old age has the potential to translate into strategies that promote healthy aging and extend life span. This review summarizes our current understanding of the configuration of the age-related gut microbiota and its likely role in determining the immune phenotype in the elderly. It also highlights the specific components of the microbiota that can be targeted to modulate the age-related chronic inflammation.

16 October 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LLLei Lei
Lei Lei
STSoumba Traore
Soumba Traore
GIGuillermo S. Romano Ibarra
Guillermo S. Romano Ibarra
PKPhilip H. Karp
Philip H. Karp
TRTayyab Rehman
Tayyab Rehman
ITIan M Thornell
Ian M Thornell
The volume and composition of a thin layer of liquid covering the airway surface defend the lung from inhaled pathogens and debris. Airway epithelia secrete Cl– into the airway surface liquid through cystic fibrosis transmembrane conductance regulator (CFTR) channels, thereby increasing the volume of airway surface liquid. The discovery that pulmonary ionocytes contain high levels of CFTR led us to predict that ionocytes drive secretion. However, we found the opposite. Elevating ionocyte abundance increased liquid absorption, whereas reducing ionocyte abundance increased secretion. In contrast to other airway epithelial cells, ionocytes contained barttin/Cl– channels in their basolateral membrane. Disrupting barttin/Cl– channel function impaired liquid absorption, and overexpressing barttin/Cl– channels increased absorption. Together, apical CFTR and basolateral barttin/Cl– channels provide an electrically conductive pathway for Cl– flow through ionocytes, and the transepithelial voltage generated by apical Na+ channels drives absorption. These findings indicate that ionocytes mediate liquid absorption, and secretory cells mediate liquid secretion. Segregating these counteracting activities to distinct cell types enables epithelia to precisely control the airway surface. Moreover, the divergent role of CFTR in ionocytes and secretory cells suggests that cystic fibrosis disrupts both liquid secretion and absorption.

16 August 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
TRTayyab Rehman
Tayyab Rehman
PKPhilip H. Karp
Philip H. Karp
PTPing Tan
Ping Tan
BGBrian J. Goodell
Brian J. Goodell
APAlejandro A. Pezzulo
Alejandro A. Pezzulo
MWMichael J. Welsh
Michael J. Welsh
Without cystic fibrosis transmembrane conductance regulator–mediated (CFTR-mediated) HCO3– secretion, airway epithelia of newborns with cystic fibrosis (CF) produce an abnormally acidic airway surface liquid (ASL), and the decreased pH impairs respiratory host defenses. However, within a few months of birth, ASL pH increases to match that in non-CF airways. Although the physiological basis for the increase is unknown, this time course matches the development of inflammation in CF airways. To learn whether inflammation alters CF ASL pH, we treated CF epithelia with TNF-α and IL-17 (TNF-α+IL-17), 2 inflammatory cytokines that are elevated in CF airways. TNF-α+IL-17 markedly increased ASL pH by upregulating pendrin, an apical Cl–/HCO3– exchanger. Moreover, when CF epithelia were exposed to TNF-α+IL-17, clinically approved CFTR modulators further alkalinized ASL pH. As predicted by these results, in vivo data revealed a positive correlation between airway inflammation and CFTR modulator–induced improvement in lung function. These findings suggest that inflammation is a key regulator of HCO3– secretion in CF airways. Thus, they explain earlier observations that ASL pH increases after birth and indicate that, for similar levels of inflammation, the pH of CF ASL is abnormally acidic. These results also suggest that a non-cell-autonomous mechanism, airway inflammation, is an important determinant of the response to CFTR modulators.

1 January 2014 in Chest
Verified
Journal Article
Closed access
PDF file
TRTayyab Rehman
Tayyab Rehman
BDBennett P. Deboisblanc
Bennett P. Deboisblanc

1 October 2015 in Chest
Verified
Journal Article
Closed access
MLMatthew R. Lammi
Matthew R. Lammi
BABrianne Aiello
Brianne Aiello
GBGregory T. Burg
Gregory T. Burg
TRTayyab Rehman
Tayyab Rehman
IDIvor S. Douglas
Ivor S. Douglas
BDBennett P. Deboisblanc
Bennett P. Deboisblanc

1 August 2020 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
TRTayyab Rehman
Tayyab Rehman
ITIan M Thornell
Ian M Thornell
APAlejandro A. Pezzulo
Alejandro A. Pezzulo
ATAndrew L. Thurman
Andrew L. Thurman
GIGuillermo S. Romano Ibarra
Guillermo S. Romano Ibarra
MWMichael J. Welsh
Michael J. Welsh
The pH of airway surface liquid (ASL) is a key factor that determines respiratory host defense; ASL acidification impairs and alkalinization enhances key defense mechanisms. Under healthy conditions, airway epithelia secrete base ([ ]) and acid (H+) to control ASL pH (pHASL). Neutrophil-predominant inflammation is a hallmark of several airway diseases, and TNFα and IL-17 are key drivers. However, how these cytokines perturb pHASL regulation is uncertain. In primary cultures of differentiated human airway epithelia, TNFα decreased and IL-17 did not change pHASL. However, the combination (TNFα+IL-17) markedly increased pHASL by increasing [ ] secretion. TNFα+IL-17 increased expression and function of two apical [ ] transporters, CFTR anion channels and pendrin Cl−/[ ] exchangers. Both were required for maximal alkalinization. TNFα+IL-17 induced pendrin expression primarily in secretory cells where it was coexpressed with CFTR. Interestingly, significant pendrin expression was not detected in CFTR-rich ionocytes. These results indicate that TNFα+IL-17 stimulate [ ] secretion via CFTR and pendrin to alkalinize ASL, which may represent an important defense mechanism in inflamed airways.